Skip to main content
. 2023 Jun;29(6):1236–1239. doi: 10.3201/eid2906.230128

Table 2. Cohorts of dromedary camels by MERS-CoV seroprevalence and vaccine candidate used Dubai, United Arab Emirates*.

Category Type Vaccine candidate
Total
MVA MVA-MERS-S
MERS-CoV infection Naive 1 3 4
Seropositive 3 5 8
Total 4 8 12

*MERS-CoV, Middle East respiratory syndrome coronavirus; MVA, modified vaccinia virus Ankara; MVA-MERS-S, modified vaccinia virus Ankara expressing full-length MERS-CoV spike protein as antigen.